摘要
目的:观察多奈哌齐治疗血管性痴呆的疗效及安全性。方法:采用自身对照研究,36例血管性痴呆患者服用多奈哌齐治疗12周,治疗前及治疗后第4、12周各用简易智能精神状态检查量表(MMSE)和日常生活活动能力量表(ADL)评定疗效,并进行安全性评价。结果:多奈哌齐治疗12周后MMSE评分较治疗前提高3.6分,ADL评分较治疗前下降7.3分,差异均有显著性意义;3例(8.33%)出现轻度不良反应,均为一过性反应。结论:多奈哌齐治疗血管性痴呆有较好的疗效且安全性好。
Objective: To observe the efficacy and safety of donepezil in treatment of vascular dementia (VaD). Methods: The selfmatched method was adopted. 36 patients with VaD wen give orally donepezil for 12 weeks. The efficacies wen assessed with MMSE & ADL, and the safety after the treatment was also assessed.Results:The score of MMSE increased 3.6 points, while that of ADL decnased 7.3 points after treatment with donepezil for 12 weeks, the diffennees were significant. Then were 3 patients (8.33%) shewing mild side- effect which was temporary phenomenon. Conclusion: It is effective and safe to treat patients with VaD.
出处
《医学理论与实践》
2006年第2期136-137,共2页
The Journal of Medical Theory and Practice
关键词
多奈哌齐
血管性痴呆
治疗
Donepezil, Vascular dementia, Treatment